Biotechnology
Biotechnology Contract Management Software
The contract intelligence platform built for biotech to manage contracts, maximize profitability, and streamline compliance. Contract Logix turns the milestone schedules, tiered royalties, diligence obligations, and supply commitments buried in your licensing, collaboration, and clinical agreements into structured data your teams can act on.
The problem we solve
A single biotech program can depend on an in-licensed patent estate, a university material transfer agreement, a CDMO supply contract, a clinical trial network, and an out-licensing deal that returns milestones and royalties for a decade. The value is not in the document, it is in the structured terms inside it.
Milestone tracking across the portfolio
A single out-license can carry a dozen development, regulatory, and commercial milestones triggered years apart, so a payment is often discovered only after the counterparty invoices, with no advance line of sight.
Royalty obligation tracking
Tiered royalty rates that step with net sales, combined with floors, caps, and stacking offsets, make royalty diligence and audit defense slow and error-prone when terms are scattered across the repository.
Diligence-obligation deadlines
In-licenses impose diligence obligations, hit a development stage by a date, spend a minimum, file in named territories, and a missed deadline can convert a license to nonexclusive or lose it entirely.
Sublicense flow-down and relationship blindness
Sublicenses must stay consistent with the head license, including Bayh-Dole government rights and U.S. manufacturing preferences, and verifying flow-down by hand across standalone files is fragile.
From contract pain to contract intelligence
Manage the contract lifecycle
A secure repository on Microsoft Azure with no-code workflow automation, parallel approval routing, role-based security, and a 6-year audit trail, plus Contract Binders that link master licenses to their amendments and sublicenses and collaboration agreements to their work orders.
Maximize profitability
The Contract Intelligence Engine extracts the financial terms buried in biotech deals, from individual milestone events and amounts to royalty tiers, FTE rates by function, sublicense income shares, and take-or-pay minimums, and puts them to work as operational data BD and finance can forecast against.
Streamline compliance
Required terms, approvals, and flow-down provisions are enforced in the workflow, so Bayh-Dole government rights, FDA and BPCIA obligations, and antitrust settlement-filing requirements stay tracked. Configurable dashboards assemble obligation and approval evidence.
Review contracts in minutes
Contract Logix Review delivers first-pass redlines in minutes, inside Microsoft Word and Google Docs, applying your organization’s own standards. Configure playbooks for royalty stacking offsets, diligence obligations, audit rights, and flow-down terms so first drafts arrive marked against house standards.
Built for every biotech agreement type
- In-licensing and out-licensing agreements. Upfront fees, development, regulatory, and commercial milestones, tiered royalties with floors and caps, sublicense income shares, field and territory limits, and audit rights, captured as structured data.
- Milestone and royalty agreements. Development, regulatory, and commercial milestone triggers and amounts, and royalty rates that step with net sales thresholds, tracked across the life of the deal.
- Collaboration and co-development agreements. FTE rates by functional group, research budgets, allowable-overrun thresholds, cost- and profit-share splits, governance committees, and work orders.
- Material transfer, sponsored research, and CRADAs. Permitted use, ownership of derivatives, publication windows, IP option terms, and the Bayh-Dole and federal flow-down obligations that travel with academic and federal IP.
- CDMO and CMO supply and quality agreements. Pricing, minimum order and capacity commitments, take-or-pay provisions, batch acceptance, and the cGMP responsibilities allocated in the paired quality agreement.
Who it serves
VP / Head of Business Development and Licensing
Compares royalty and milestone terms across counterparties before negotiating the next deal, instead of reconstructing portfolio exposure by hand. A primary economic buyer.
Alliance Manager
Tracks milestones, diligence deadlines, and reporting obligations across alliances with advance warning, not after the invoice arrives. A primary platform user.
General Counsel / Chief Legal Officer
Manages flow-down and regulatory obligations from one record, with structured terms, audit trail, and review playbooks.
Chief Financial Officer
Forecasts milestone and royalty liability and income from dashboards, rather than learning of obligations only when they are invoiced.
IP Counsel
Confirms sublicense flow-down and Bayh-Dole consistency from head license to sublicense using parent-child binders.
Head of CMC / Manufacturing
Monitors take-or-pay minimums, capacity reservations, and quality-agreement obligations across suppliers from one view.
What sets Contract Logix apart
- Line-item term extraction: milestone events, royalty tiers, FTE rates, and diligence deadlines captured as structured, queryable data rather than buried in PDFs.
- Parent-child contract modeling: Contract Binders link master licenses to amendments and sublicenses, and collaboration agreements to work orders, so flow-down and consistency are verifiable.
- Obligation-centric dashboards: configurable views for upcoming milestone payments, royalty liability by product, and the diligence-obligation calendar give BD, finance, and alliance teams forward visibility.
- Lifecycle management, line-item extraction, and AI contract review work together in Contract Logix, applying house standards on royalty stacking, diligence terms, and flow-down provisions.
- Software plus managed services on Microsoft Azure (SOC 2 Type II, HIPAA, FISMA), with playbook architecture and data migration support.
- Honest scope: Contract Logix is configurable for biotech rather than pre-loaded with biotech-specific templates; its named pre-built vertical content is healthcare.
Proven at scale
More than 60,000 professionals across hundreds of organizations run their contract operations on Contract Logix, across healthcare, financial services, insurance, life sciences, and other regulated industries. Contract Logix has built purpose-made contract software since 2013, out of Carnegie Mellon University.
Enterprise-grade security on Microsoft Azure
Microsoft Azure hosting, SOC 2 Type II, HIPAA, and FISMA compliance, AES-256 encryption, role-based access, and a 6-year audit trail for licensing, research, and trial data. See Security & trust for the full specification.
Biotechnology contract management: a complete guide
In biotech, the contract is where the science becomes a business, and where the obligations that govern that business live. This guide explains why biotechnology contract management matters and the practices that keep milestone, royalty, and diligence obligations under control.
What is biotechnology contract management?
Biotechnology contract management applies contract lifecycle management to the in-licenses, out-licenses, collaborations, material transfers, supply agreements, and clinical trial agreements that carry a program from discovery to commercialization. It covers negotiating and executing terms, then monitoring and enforcing the financial and regulatory obligations across the life of each deal.
What makes it distinct is density and interdependence. An out-license carries milestone payments and tiered royalties with floors, caps, and stacking offsets; a collaboration adds FTE-funded research and option fees; and a head license imposes flow-down terms that every sublicense must inherit.
Why it is critical
When milestone definitions, royalty tiers, and diligence deadlines live only in PDFs and spreadsheets, a missed milestone notice or an under-reported royalty becomes a financial and relationship risk that surfaces too late to manage. Diligence deadlines can cost a license, royalty stacking can erode product economics, and sublicense flow-down gaps can breach the head license.
Structuring those terms turns reactive discovery into proactive management, so teams forecast cash, defend royalty audits, and protect the value of every deal.
Biotechnology CLM best practices
- Use standard templates and clear positions for licensing, collaboration, and supply agreements.
- Track milestone triggers, royalty reporting dates, and diligence deadlines in one system with advance alerts.
- Automate intake and parallel approval routing across BD, legal, finance, and alliance management.
- Verify sublicense flow-down against the head license, including Bayh-Dole government rights and U.S. manufacturing preferences.
- Extract the line-item data inside contracts, from milestone events and royalty tiers to FTE rates and take-or-pay minimums, so finance can forecast obligations and income.
- Keep accurate, searchable records of every license and its amendments so changes to economics surface quickly.
What to look for in biotechnology CLM software
- Line-item extraction with fields you define and reprocess as reporting requirements change.
- Parent-child modeling for master-to-sublicense and collaboration-to-work-order relationships.
- Obligation-centric dashboards for milestone payments, royalty liability by product, and diligence deadlines.
- A no-code workflow designer with parallel approval routing for negotiation-heavy deals.
- AI-assisted contract review and redlining against your own standards on stacking, diligence, and flow-down.
- Enterprise security and a long audit trail, hosted on Microsoft Azure.
- Integration with the ERP, finance, and e-signature systems you already run.
How Contract Logix helps
Contract Logix gives biotech teams a configurable platform to author and negotiate deals, extract their line-item terms, and apply playbook-driven first-pass review, on infrastructure certified to SOC 2 Type II, HIPAA, and FISMA. Obligation-centric dashboards give BD, finance, and alliance management forward visibility, and professional services support teams without deep internal CLM resources.
Frequently asked questions
- What makes biotechnology contract management different?
- Biotech contracts hold dense, interdependent financial and legal terms: milestone schedules, tiered royalties with floors, caps, and stacking offsets, FTE-funded collaborations, and flow-down obligations that every sublicense must inherit. Biotechnology contract management captures those terms as structured data and keeps the master-to-sublicense relationships explicit.
- How does it help track milestones and royalties?
- The Contract Intelligence Engine extracts individual milestone events and amounts and each royalty tier and rate, and configurable dashboards show upcoming milestone payments and royalty liability by product, with stacking offsets applied, so BD and finance forecast obligations and defend royalty audits.
- Can it manage diligence-obligation deadlines?
- Yes. Development, spend, and filing deadlines from in-licenses are captured as structured data and surfaced on a diligence-obligation calendar, so obligations that could convert or forfeit a license are managed in advance rather than discovered late.
- How does it handle sublicense flow-down and Bayh-Dole?
- Contract Binders link the head license to its sublicenses, so IP counsel can verify that government rights, U.S. manufacturing preferences, and other flow-down terms are carried consistently from master to sublicense. This is general information, not legal advice.
- Does Contract Logix offer pre-built biotech templates?
- No. Contract Logix is configurable for biotech rather than pre-loaded with biotech-specific content; its named pre-built vertical content is healthcare. Biotech deployments rely on the configurable platform plus professional services for playbook architecture and data migration.
- Is it secure and audit-ready?
- Contract Logix runs on Microsoft Azure and is SOC 2 Type II, HIPAA, and FISMA compliant, with role-based access and a 6-year audit trail for licensing, research, and trial data.
